Rebecca Clark
@raclark18.bsky.social
310 followers 110 following 7 posts
Assistant Professor in the TB Modelling Group at LSHTM modelling TB vaccines👩🏼‍💻💉📚🇨🇦🇬🇧
Posts Media Videos Starter Packs
Reposted by Rebecca Clark
kchorton.bsky.social
1/ It’s been 10 years (😮) since we reported that #TB prevalence was twice as high in men as in women.

📢 Our new preprint explores how sex differences have shifted with more recent national prevalence surveys and growing attention to #gender responsive TB prevention and care.

bit.ly/4gqP1LH
Differences in Tuberculosis Prevalence by Sex Over 1993-2024: A Systematic Review and Meta-Analysis
Background: Tuberculosis (TB) prevalence is higher among men than women in low- and middle-income countries (LMICs). However, summary measures of sex difference
bit.ly
Reposted by Rebecca Clark
Reposted by Rebecca Clark
kchorton.bsky.social
At a time when global resources for #TB research, development, prevention, and care are limited, which interventions should be prioritised in high burden settings?

📢 Our new pre-print compares the impact, cost, and cost-effectiveness of 9 TB interventions in 3 countries. 1/n

bit.ly/3V3vXth
The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exercise
Background While a range of interventions exist for tuberculosis prevention, screening, diagnosis, and treatment, their potential population impact and cost-effectiveness are seldom directly compared,...
bit.ly
Reposted by Rebecca Clark
kchorton.bsky.social
Community screening for #tuberculosis could extend the reach of #TB services, but evidence on its effectiveness is limited.

In our latest preprint, we examine the epidemiological impact of trade-offs in diagnostic algorithm, population coverage, and duration of screening. 1/n

bit.ly/3UK7pFD
Exploring trade-offs in diagnostic algorithm, population coverage, and duration of community screening for tuberculosis
Background Current tuberculosis (TB) prevention and care strategies have failed to reduce disease burden at the pace required to meet global targets. Community screening may enable more rapid declines...
www.medrxiv.org
Reposted by Rebecca Clark
raclark18.bsky.social
Reduced international donor funding through not only the termination of #USAID, but also announced reductions in donor pledges to #TheGlobalFund from other countries, could lead to substantial potential impacts on #TB morbidity and mortality.

Read how in our new study in @lancetgh.bsky.social 👇
Reposted by Rebecca Clark
kchorton.bsky.social
New systematic review led by @hannahrickman.bsky.social shows annual risk of Mycobacterium #tuberculosis conversion in men and women diverges during adolescence and remains higher among men throughout adulthood.

www.thelancet.com/journals/lan...
The figure shows two graphs, both with age on the x-axis and separate curves for males and females. In the top figure, the y-axis shows prevalence of Mtb immunoreactivity; in the bottom figure, the y-axis shows annual risk of Mtb conversion. In both figures, the curves for males and females diverge from adolescence and remain higher for men than women through adulthood.
Reposted by Rebecca Clark
kchorton.bsky.social
In our latest personal view in @lancetrespirmed.bsky.social, we argue for the inclusion asymptomatic #tuberculosis in vaccine trial endpoints to potentially reduce the size, length, and cost of trials.

doi.org/10.1016/S221...

@lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
Figure 1. Estimated number of trial endpoints in the control group of a prevention-of-disease vaccine trial in a high disease-burden setting showing number of endpoints on the y-axis and time in months on the x-axis. For bacteriologically confirmed symptomatic tuberculosis disease endpoints only, we estimate 69 endpoints, and for combined bacteriologically confirmed asymptomatic and symptomatic tuberculosis disease endpoints, we estimate 151 endpoints. Scenario assumes symptomatic disease incidence before trial screening of 300/100 000 per year and following 10 000 individuals over 3 years. Prevalent symptomatic and asymptomatic tuberculosis disease are screened out in month 0 and are not trial endpoints. Active screening occurs every 6 months for both scenarios and participants self-presenting with symptoms suggestive of tuberculosis disease would also be investigated.
Reposted by Rebecca Clark
Reposted by Rebecca Clark
reinhouben.bsky.social
Amid all the bad news in Global Health, perhaps some good news? A first analysis on the risk of false positive diagnoses in community-screening for tuberculosis using Xpert shows our clinic-based data is likely (very) wrong and overestimates false positives by >80%: tinyurl.com/yfecute9.
Reposted by Rebecca Clark
iddjobs.org
IDDjobs @iddjobs.org · May 20
Postdoc (London, UK)
Position available in the world-leading tuberculosis (TB) Modelling group at LSHTM
with @raclark18.bsky.social@richardwhite321.bsky.social
at LSHTM @lshtm-tbmod.bsky.social
More details: http://iddjobs.org/jobs/2314
Reposted by Rebecca Clark
Reposted by Rebecca Clark
lshtm-vaccines.bsky.social
🙋Interested in finding out about #vaccine hesitancy?💉

Join us for our Annual Lecture on Monday 19 May for an opportunity to hear from Prof Stephan Lewandowsky @bristolunipsych.bsky.social & network with colleagues @lshtm.bsky.social & the Vaccine Centre.🍹🤝

👉 www.lshtm.ac.uk/newsevents/e...
Reposted by Rebecca Clark
lshtm-vaccines.bsky.social
Our first #WorldImmunizationWeek podcast episode is live now!

Tune in to hear from @emprestige.bsky.social about their journey from MSc to PhD @lshtm.bsky.social. They also share insider tips on the best lunch spots in central London, so don't miss this.

soundcloud.com/user-7893872...
Reposted by Rebecca Clark
kchorton.bsky.social
Reductions in contributions to The Global Fund in line with current announcements by the United States, France, the United Kingdom, and Germany may lead to an additional 699,200, 63,100, 50,500, and 30,500 TB deaths, respectively. (See table for episodes of disease and other donor countries.) 4/8
Table showing excess symptomatic TB episodes and excess TB deaths expected for different funding scenarios, including termination of USAID funding and reductions in Global Fund funding in line with expected reductions in donor countries' overseas development assistance.
Reposted by Rebecca Clark
Reposted by Rebecca Clark
kchorton.bsky.social
Modelling projects the devastating impacts of US funding cuts, including our estimates of #TB incidence and deaths @lshtm-tbmod.bsky.social @tb-lshtm.bsky.social
altcdc.altgov.info
A Lancet preprint estimates that if US funding is cut and not replaced, from 2025-2040 there will be 15.2 mil add'l AIDS deaths, 2.2 mil add'l TB deaths, 7.9 mil add'l child deaths from other causes, and 40-55 mil add'l unplanned pregnancies.

@altusaid.altgov.info

papers.ssrn.com/sol3/papers....
A line graph of estimated AIDS-related deaths from 2025 through 2040 in 55 PEPFAR-supported countries. The Y axis is estimated number of deaths and ranges from 200,000 to 2 million. The X axis is years and ranges from 2010 to 2040. There is a black line labeled “historical trend” from 2010 to 2025 showing a decrease in deaths from 1.2 million to ~420,000. Then in 2025 the black line splits into three scenarios: 1) a dashed green line showing deaths if USAID were to increase, 2) a dashed blue line showing deaths if USAID remained at 2024 levels, and 3) a dashed red line showing deaths if USAID stopped and was not replaced. In scenario 1 (funding increased) deaths continue to decrease from ~420,000 to 200,000. In scenario 2 (funding stays the same) deaths stay the same at 420,000. In scenario 3 (funding cut and not replaced) deaths increase from ~420,000 to 1.7 million.
Reposted by Rebecca Clark
lshtm-vaccines.bsky.social
🗓️ Coming up in May!

We are excited to welcome David Miles for our next seminar. This will cover a brief history of vaccinology, from Edward Jenner's first smallpox #vaccination to modern vaccine technology.

🗓️ 8 May
⏲️ 12.50 BST
📍LSHTM | Online
🔗 www.lshtm.ac.uk/newsevents/e...
Reposted by Rebecca Clark
kchorton.bsky.social
New pre-print modelling impact of US funding cuts on HIV, #TB, MCH and family planning. We estimate impact of termination of US funding to NTPs via #USAID & The Global Fund may lead to 2.2 (1.5-2.9) million excess TB deaths between 2025 and 2040, reversing over a decade of progress.

bit.ly/4lowp18
Line chart showing median number of TB deaths in 79 low- and middle-income countries from 2010 through 2040. A black line shows a decline from 1.25 million deaths in 2010 to just under 1 million deaths in 2024. A blue line shows the number of deaths staying constant through 2040 if 2024 funding and programmes are maintained. A red line shows the number of deaths increasing to 1.2 million in 2040 if US funding to national TB programmes is terminated.
Reposted by Rebecca Clark
lshtm-malaria.bsky.social
📢 Learn to model infectious diseases & inform public health decisions @lshtm.bsky.social

This hands-on course equips health professionals, researchers, and policymakers with essential epidemiological modelling skills.

📅 16–27 June 2025 | Hybrid
Apply now 👇
🔗 bit.ly/4iE45py